Evaluation of neural transmission in implanted patients with Meniere's disease

Meniere's disease (MD) is characterised by fluctuating hearing loss. When hearing loss is severe or profound, rehabilitation requires cochlear implantation. The aim of this retrospective study was to compare cochlear implant (CI) fittings and electrode impedances between patients implanted because of MD and those with other aetiologies.

Continue reading at PubMed →

Neural transmission data in Ménière's cochlear implant recipients can inform candidacy and programming decisions; clinicians implanting this population should monitor electrophysiological markers of nerve health, though larger controlled studies are needed before changing standard protocols.

As cochlear implantation becomes an increasingly accepted option for end-stage Ménière's disease, understanding neural transmission integrity in this specific population guides appropriate candidacy criteria and device programming.

1. 01Evaluates neural transmission (electrophysiological nerve health) in cochlear implant users with Ménière's disease.
2. 02Ménière's disease causes fluctuating hearing loss that can eventually lead to severe/profound loss and CI candidacy.
3. 03Published in Acta Otorhinolaryngologica Italica (2026).
4. 04Findings have direct relevance for CI programming and outcome prediction in this underserved subgroup.
5. 05Study design and sample size not specified in the abstract — limits strength of conclusions.

PMID

42708441

DOI

10.14639/0392-100X-A1663.

Journal

Acta Otorhinolaryngologica Italica

Publication type

research_article

Evidence level

4

Population

Cochlear implant recipients with Ménière's disease and fluctuating hearing loss

Intervention

Evaluation of neural transmission via electrophysiological measures in cochlear implant users